CVE-2025-47279
Multiple vulnerabilities were discovered in IBM products. Some of them allow an attacker to cause remote arbitrary code execution, privilege escalation, and remote denial of service.
CSIRTS triage
- What
- Multiple vulnerabilities across IBM products allow remote arbitrary code execution, privilege escalation, and remote denial of service.
- Who is affected
- Multiple IBM product deployments are affected.
- Urgency
- Critical; vulnerabilities enabling remote code execution and privilege escalation across IBM products require urgent remediation.
- Action
- Identify affected IBM products from CVE details and apply vendor-specific patches.
AI-assisted analysis generated from the source advisory — verify against the original.
⚡ Watch CVE-2025-47279
Get an email if CVE-2025-47279 is added to CISA KEV, gains public exploit code, or a new advisory cites it — max one per day, one-click unsubscribe.
Exploitation outlook
- Low exploitation risk0.30% 30-day exploitation probability — currently an unlikely target, but scores change as exploit code circulates. Riskier than 22% of all EPSS-scored CVEs.
Advisory coverage (1)
- unknownexploitedMultiple vulnerabilities in IBM products (August 28, 2026)cert-fr-avis · 2026-08-28
External references
Embed the live status
— this badge updates automatically when the KEV or exploit status changes. How to embed it →
[](https://www.csirts.com/cve/CVE-2025-47279)